Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (TCTR20250911002) titled 'The comparison of the efficacy of using a Intranasal decongestant combined with a intranasal corticosteroid versus double dose Intranasal corticosteroid in moderate to severe allergic rhinitis patient' on Sept. 11.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Bannawat Tantikun

Condition: Allergic Rhinitis Rhinitis, Allergic, Perennial Quality of Life Rhinitis, Allergic, Perennial Quality of Life

Intervention: Intranasal Fluticasone furoate 2 puffs each nostril once daily + Intranasal oxymetazoline 2 puffs each nostril twice daily,Intranasal Fluticasone furoate 2 puffs each nostril ...